29

Sep

2020

17:30

BST

Webinar

Emerging Clinical Evidence on Left Atrial Appendage Closure: A Case-based Discussion

  • Views:

    Views Icon 81
  • Likes:

    Heart Icon 2

Overview

LAA closure (LAAC) is a proven alternative to oral anticoagulation for preventing stroke in patients with non-valvular AF. In the era of NOACs the clinical evidence is also emerging. Join the panelists to discuss the implications of current and future trials on clinical practice. A live case from the University Clinic Aarhus, Denmark will focus on intracardiac echocardiography (ICE) to guide the LAA closure procedure with the next generation device WATCHMAN FLX.

Performed By:

Ignacio Cruz

Ignacio Cruz

Jens Erik Nielsen-Kudsk

Jens Erik Nielsen-Kudsk

Prof Henning Ebelt

Prof Henning Ebelt

Prof Marek Grygier

Prof Marek Grygier

Moderated By:

Tim Betts

Tim Betts

Caroline Kleinecke

Caroline Kleinecke

This webinar is supported by:

Learning Objectives

  • Discuss the emerging evidence for the LAA closure therapy in the era of NOACs
  • Follow a live case with WATCHMAN FLX guided by ICE imaging
  • Learn how new workstreams with ICE can reduce the need for General Anaesthesia
  • Understand the benefits of combined procedures (AF Ablation + LAA closure) for patients
  • Learn about the trial design and endpoints of the OPTION trial and discuss the implication on clinical practice.
  • Understand how the new implantation technique of WATCHMAN FLX can optimize procedural results

Audience

  • Interventional Cardiologists and Electrophysiologists who would like to learn more about the growing evidence for the LAA closure therapy with WATCHMAN FLX
  • Non-invasive Cardiologists with an interest in the clinical evidence and the implications for the LAA closure therapy

Faculty Biographies

Ignacio Cruz

Ignacio Cruz

Prof Cruz is a Professor of Medicine at the University of Salamanca, Chief of Interventional Cardiology and Elected President of the Spanish Society of Interventional Cardiology. He is a leading and pioneering interventional cardiologist and the main driver behind the Salamanca-based interventional cardiology meetings. He is also highly involved in the research for structural intervention solutions. He is a true pioneer in the field of paravalvular leak closure and the driving force behind the HOLE-registry with 500 reported PVL cases.

View full profile
Jens Erik Nielsen-Kudsk

Jens Erik Nielsen-Kudsk

Aarhus University, Aarhus, DK

View full profile
Prof Henning Ebelt

Prof Henning Ebelt

Catholic Hospital 'St Johann Nepomuk', Erfurt, Germany

View full profile
Prof Marek Grygier

Prof Marek Grygier

Poznan University of Medical Sciences, Poznan, Poland

View full profile
Tim Betts

Tim Betts

John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, UK

Professor Betts is a Consultant in Cardiology and Cardiac Electrophysiology at the Oxford Private Heart and Lung Centre at Nuffield Health Oxford, The Manor Hospital. He also works at the Oxford University Hospitals NHS Trust.

View full profile
Caroline Kleinecke

Caroline Kleinecke

View full profile

Key References

1. OPTION

https://www.bostonscientific.com/en-US/products/laac-system/option-clinical-trial.html

https://clinicaltrials.gov/ct2/show/NCT03795298

2. ICE-LAA

https://clinicaltrials.gov/ct2/show/NCT04196335

3. ASAP TOO

https://www.bostonscientific.com/en-US/products/laac-system/asap-too.html

https://clinicaltrials.gov/ct2/show/NCT02928497